Walleye Trading’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Sell
10,800
-5,900
-35% -$128K ﹤0.01% 3094
2025
Q4
$367K Buy
16,700
+300
+2% +$5.41K ﹤0.01% 3022
2025
Q3
$199K Sell
16,400
-700
-4% -$9.47K ﹤0.01% 3371
2025
Q2
$319K Buy
+17,100
New +$339K ﹤0.01% 2951
2024
Q4
Sell
-5,000
Closed -$212K 4677
2024
Q3
$212K Sell
5,000
-1,500
-23% -$63.6K ﹤0.01% 3026
2024
Q2
$262K Buy
6,500
+600
+10% +$25K ﹤0.01% 2919
2024
Q1
$209K Sell
5,900
-5,900
-50% -$158K ﹤0.01% 3395
2023
Q4
$349K Buy
11,800
+4,200
+55% +$87.1K ﹤0.01% 3383
2023
Q3
$158K Buy
+7,600
New +$209K ﹤0.01% 3746
2023
Q1
Sell
-46,300
Closed -$2.08M 5402
2022
Q4
$2.08M Sell
46,300
-4,300
-8% -$195K 0.01% 1648
2022
Q3
$2.42M Buy
50,600
+26,200
+107% +$1.44M 0.01% 1552
2022
Q2
$1.44M Buy
24,400
+18,400
+307% +$1.51M ﹤0.01% 1930
2022
Q1
$698K Sell
6,000
-17,400
-74% -$2.03M ﹤0.01% 2569
2021
Q4
$3.52M Buy
+23,400
New +$3.16M 0.01% 1214
2021
Q3
Sell
-500
Closed -$49K 5720
2021
Q2
$49K Buy
+500
New +$44.6K ﹤0.01% 4630
2021
Q1
Sell
-500
Closed -$48K 5300
2020
Q4
$48K Sell
500
-4,100
-89% -$423K ﹤0.01% 4189
2020
Q3
$522K Buy
4,600
+2,300
+100% +$242K ﹤0.01% 2210
2020
Q2
$228K Buy
2,300
+1,200
+109% +$95.8K ﹤0.01% 2974
2020
Q1
$71K Sell
1,100
-20,200
-95% -$1.42M ﹤0.01% 3298
2019
Q4
$1.27M Buy
21,300
+17,600
+476% +$1.09M 0.01% 1593
2019
Q3
$218K Sell
3,700
-300
-8% -$19.1K ﹤0.01% 2866
2019
Q2
$258K Sell
4,000
-1,200
-23% -$77.4K ﹤0.01% 2744
2019
Q1
$330K Sell
5,200
-7,200
-58% -$378K ﹤0.01% 2627
2018
Q4
$471K Buy
+12,400
New +$438K ﹤0.01% 2533

Other funds holding TNDM

Walleye Trading's TNDM Position: Q1 2026 in Review

Walleye Trading sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 9,358 shares — an estimated $203K sold.

Walleye Trading first reported a position in TNDM in Q1 2019 and held it in 12 quarters. The position peaked at $620K in Q4 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Walleye Trading reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 9,358 Tandem Diabetes Care shares in Q1 2026, an estimated $203K.
  • Walleye Trading first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 12 quarters.
  • Walleye Trading's Tandem Diabetes Care position peaked at $620K in Q4 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.